|
|
接受卡度尼利单抗治疗的胃腺癌并发肺肿瘤血栓性微血管病1例并文献复习
|
Abstract:
肺肿瘤血栓性微血管病(PTTM)是一种罕见的、快速进展且致命的肿瘤相关并发症，患者通常在发病后短期内进展至死亡。目前，国内报道的病例多因呼吸系统症状首诊，发病前无明确的肿瘤病史，临床早期诊断困难，接受系统性抗肿瘤治疗后肿瘤控制稳定却仍出现PTTM的病例更鲜有报道。因此我们报道了1例在接受免疫治疗后出现肺肿瘤血栓性微血管病的胃腺癌患者，并结合相关文献对病例进行总结，为临床中对肺肿瘤血栓性微血管病的早期鉴别及诊治提供经验。
Pulmonary Tumor Thrombotic Microangiopathy (PTTM) is a rare, rapidly progressive and fatal tu-mor-related complication, and patients usually progress to death within a short period of time after onset. Currently, most of the cases reported in China were first diagnosed with respiratory symp-toms without a clear history of tumor prior to the onset of the disease, which made early clinical di-agnosis difficult, and fewer cases were reported in which PTTM occurred despite stable tumor con-trol after receiving systemic antitumor therapy. Therefore, we report a case of gastric adenocarci-noma patient who developed PTTM after receiving immunotherapy, and summarize the case with relevant literature to provide experience in early identification and diagnosis of PTTM in clinical practice.
| [1] | Von Herbay, A., Illes, A., Waldherr, R. and Otto, H.F. (1990) Pulmonary Tumor Thrombotic Microangiopathy with Pulmonary Hypertension. Cancer, 66, 587-592.
https://doi.org/10.1002/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J |
| [2] | Godbole, R.H., Saggar, R. and Kamangar, N. (2019) Pulmonary Tumor Thrombotic Microangiopathy: A Systematic Review. Pulmonary Circulation, 9, 1-13. https://doi.org/10.1177/2045894019851000 |
| [3] | Uruga, H., Fujii, T., Kurosaki, A., Hanada, S., Takaya, H., Miyamoto, A., et al. (2013) Pulmonary Tumor Thrombotic Microangiopathy: A Clinical Analysis of 30 Autopsy Cases. Internal Medicine, 52, 1317-1323.
https://doi.org/10.2169/internalmedicine.52.9472 |
| [4] | 占丰富, 张孝斌, 黄茂宏, 等. 肺肿瘤血栓性微血管病2例报道并文献复习[J]. 疑难病杂志, 2022, 21(7): 736-741. |
| [5] | Sato, N., Tasaki, T., Noguchi, H., Irie, K. and Naka-yama, T. (2019) The Pathological Challenge of Establishing a Precise Diagnosis for Pulmonary Tumour Thrombotic Mi-croangiopathy: Identification of New Diagnostic Criteria. Histopathology, 74, 892-901. https://doi.org/10.1111/his.13813 |
| [6] | Kamada, H., Ota, H., Terui, Y., Sugimura, K., Fukui, S., Shimokawa, H., et al. (2020) Three Cases of Pulmonary Tumor Thrombotic Microangiopathy (PTTM): Challenge in Antemortem Diagnosis Using Lung Perfusion Blood Volume Images by Dual-Energy Computed Tomography. European Journal of Radiology Open, 7, 100212.
https://doi.org/10.1016/j.ejro.2020.01.001 |
| [7] | Kumar, N., Price, L.C., Montero, M.A., Dimopoulos, K., Wells, A.U. and Wort, S.J. (2015) Pulmonary Tumour Thrombotic Microangiopathy: Unclassifiable Pulmonary Hypertension. European Respiratory Journal, 46, 1214-1217.
https://doi.org/10.1183/13993003.00052-2015 |
| [8] | Aklilu, A.M.M. and Shirali, A.C.C. (2023) Chemothera-py-Associated Thrombotic Microangiopathy. Kidney360, 4, 409-422. https://doi.org/10.34067/KID.0000000000000061 |
| [9] | Font, C., De Herreros, M.G., Tsoukalas, N., Brito-Dellan, N., Esposito, F., Escalante, C., et al. (2022) Thrombotic Microangiopathy (TMA) in Adult Patients with Solid Tumors: A Challenging Complication in the Era of Emerging Anticancer Therapies. Supportive Care in Cancer, 30, 8599-8609. https://doi.org/10.1007/s00520-022-06935-5 |
| [10] | Pang, X., Huang, Z., Zhong, T., Zhang, P., Wang, Z.M., et al. (2023) Cadonilimab, a Tetravalent PD-1/CTLA-4 Bispecific Antibody with Trans-Binding and Enhanced Target Binding Avidity. mABs, 15, Article 2180794.
https://doi.org/10.1080/19420862.2023.2180794 |
| [11] | Horino, T., Eguchi, T., Inotani, S., Hirose, A., Ishihara, M., Yagyu, K., et al. (2023) Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab. Internal Medicine, 62, 91-94. https://doi.org/10.2169/internalmedicine.9425-22 |
| [12] | Lancelot, M., Miller, M.J., Roback, J. and Stowell, S.R. (2021) Refractory Thrombotic Thrombocytopenic Purpura Related to Checkpoint Inhibitor Immunotherapy. Transfusion, 61, 322-328. https://doi.org/10.1111/trf.16117 |
| [13] | Muniz, T.P., Patriquin, C.J. and Saibil, S.D. (2021) Presumed Complement-Mediated, Checkpoint Inhibitor-Induced, Thrombotic Microangiopathy in a Patient with Metastatic Mela-noma. BMJ Case Reports, 14, e242075.
https://doi.org/10.1136/bcr-2021-242075 |
| [14] | Utsu, Y., Kawakami, M., Arai, H., Hisamatsu, H., Yano, Y. and Terada, J. (2023) Pulmonary Tumor Thrombotic Microangiopathy during Good Response to Immuno-Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Case Report. BMC Pulmonary Medicine, 23, Article No. 124. https://doi.org/10.1186/s12890-023-02419-2 |
| [15] | Toyonaga, H., Tsuchiya, M., Sakaguchi, C., Ajimizu, H., Nakanishi, Y., Nishiyama, S., et al. (2017) Pulmonary Tumor Thrombotic Microangiopathy Caused by a Parotid Tumor: Early Antemortem Diagnosis and Long-Term Survival. Internal Medicine, 56, 67-71. https://doi.org/10.2169/internalmedicine.56.7439 |
| [16] | 郑天萍, 昝瑜珉, 许伟, 等. 宫颈鳞癌并发肺肿瘤血栓性微血管病1例并文献复习[J]. 南京医科大学学报(自然科学版), 2023, 43(10): 1470-1474. |
| [17] | 杜竺蔓, 刘春涛. 肺肿瘤血栓性微血管病研究进展[J]. 临床肺科杂志, 2021, 26(5): 780-783. |
